Are you an Australian life sciences company seeking to grow your footprint in Europe?
Austrade has partnered with Eurasante for the 12th edition of BioFIT, the leading life sciences event in Europe for technology transfer, academia-industry collaborations, early-stage innovation deals.
BioFIT is also the European marketplace for pre-seed, seed and Series A investment in life sciences.
Held on 12-13 December in Marseille and on 15 December online, BioFIT brings together TTOs, research institutes and academia together with big pharma and investors to explore partnerships, source innovative and competitive early stage R&D projects, facilitate the emergence of collaborative projects and increase licensing opportunities.
Look forward to meeting these participants:
TTOs and academia: Ascenion | BioAster | BioInnovation Institute | Cancer Research UK | EMBLEM Technology Transfer | Fraunhofer Institute for Cell Therapy and Immunology | IFOM | Imperial College London | INRAE Transfert | IOCB Tech | JUNIA | SATT Network | UCL Innovation and Enterprise | University of Birmingham | University of Oxford
Investors (pre-seed, seed, Series A): +ND Capital | AdBio Partners | BioGeneration Ventures | Cambridge Innovation Capital | Capital Grand Est | EQT Life Sciences | eureKARE | European Investment Fund | Forbion | Fund+ | Health Innovation Capital | High-Tech Gründerfonds | INKEF Capital | Jeito | Novo Holdings A/S | Novo Seeds | Sofinnova Partners | SV Health investors | Syncona | Theodorus Investment Funds | TVM Capital Life Science | V-Bio Ventures
Austrade Business Development Manager, Paris